Saranda Medical Ltd 11528631 false 2023-09-01 2024-08-31 2024-08-31 The principal activity of the company is medical services. Digita Accounts Production Advanced 6.30.9574.0 true false 11528631 2023-09-01 2024-08-31 11528631 2024-08-31 11528631 core:RetainedEarningsAccumulatedLosses 2024-08-31 11528631 core:ShareCapital 2024-08-31 11528631 core:CurrentFinancialInstruments core:WithinOneYear 2024-08-31 11528631 bus:SmallEntities 2023-09-01 2024-08-31 11528631 bus:AuditExemptWithAccountantsReport 2023-09-01 2024-08-31 11528631 bus:FullAccounts 2023-09-01 2024-08-31 11528631 bus:SmallCompaniesRegimeForAccounts 2023-09-01 2024-08-31 11528631 bus:RegisteredOffice 2023-09-01 2024-08-31 11528631 bus:Director1 2023-09-01 2024-08-31 11528631 bus:Director1 1 2023-09-01 2024-08-31 11528631 bus:Director2 2023-09-01 2024-08-31 11528631 bus:Director2 2 2023-09-01 2024-08-31 11528631 bus:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 11528631 countries:EnglandWales 2023-09-01 2024-08-31 11528631 2022-09-01 2023-08-31 11528631 2023-08-31 11528631 core:RetainedEarningsAccumulatedLosses 2023-08-31 11528631 core:ShareCapital 2023-08-31 11528631 core:CurrentFinancialInstruments core:WithinOneYear 2023-08-31 iso4217:GBP xbrli:pure

Registration number: 11528631

Saranda Medical Ltd

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 August 2024

 

Saranda Medical Ltd

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2 to 3

 

Saranda Medical Ltd

(Registration number: 11528631)
Abridged Balance Sheet as at 31 August 2024

2024
£

2023
£

Current assets

Debtors

1,899

3,414

Cash at bank and in hand

883

7,112

2,782

10,526

Creditors: Amounts falling due within one year

(2,682)

(10,262)

Net assets

100

264

Capital and reserves

Called up share capital

100

100

Profit and loss account

-

164

Total equity

100

264

For the financial year ending 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 2 April 2025 and signed on its behalf by:
 

Dr G Haxa

Director

Dr S Harmer

Director

 

Saranda Medical Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Calyx House
South Road
Taunton
Somerset
TA1 3DU

These financial statements were authorised for issue by the Board on 2 April 2025.

2

Accounting policies

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern
The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

 

Saranda Medical Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2024

4

Related party transactions

Advances to directors


Dr G Haxa

During the period Dr G Haxa went overdrawn on their director's loan account. The maximum overdrawn balance during the year was £1,433 (2023 - £1,500). At the year end the amount outstanding from Dr G Haxa was £950 (2023 - £782).


Dr S Harmer

During the period Dr S Harmer went overdrawn on their director's loan account. The maximum overdrawn balance during the year was £1,433 (2023 - £1,500). At the year end the amount outstanding from Dr S Harmer was £949 (2023 - £782).